Based on the measurements of operating efficiency obtained from Achieve Life's historical financial statements, Achieve Life Sciences may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Achieve Life's Long Term Debt is fairly stable compared to the past year. Key indicators impacting Achieve Life's financial strength include:
Investors should never underestimate Achieve Life's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Achieve Life's cash flow, debt, and profitability to make informed and accurate decisions about investing in Achieve Life Sciences.
Net Income
(28.32 Million)
Achieve
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Cash Conversion Cycle
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
Stock Based Compensation
End Period Cash Flow
Sale Purchase Of Stock
Change To Inventory
Change To Account Receivables
Investments
Change Receivables
Total Cashflows From Investing Activities
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Net Borrowings
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Non Current Assets Total
Non Currrent Assets Other
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Cash
Cash And Short Term Investments
Common Stock Total Equity
Short Term Investments
Common Stock
Current Deferred Revenue
Net Receivables
Good Will
Intangible Assets
Inventory
Net Tangible Assets
Retained Earnings Total Equity
Long Term Debt Total
Capital Surpluse
Capital Lease Obligations
Property Plant Equipment
Other Assets
Long Term Debt
Other Liab
Short Long Term Debt
Non Current Liabilities Other
Net Invested Capital
Net Working Capital
Capital Stock
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Research Development
Selling And Marketing Expenses
Net Income From Continuing Ops
Non Operating Income Net Other
Net Income Applicable To Common Shares
Non Recurring
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Achieve Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Achieve Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Achieve Life's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Achieve Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Achieve Life Sciences. Check Achieve Life's Beneish M Score to see the likelihood of Achieve Life's management manipulating its earnings.
Achieve Life Stock Summary
Achieve Life competes with Apellis Pharmaceuticals, Iteos Therapeutics, Tscan Therapeutics, Day One, and Acumen Pharmaceuticals. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Achieve Life's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Achieve Life's current stock value. Our valuation model uses many indicators to compare Achieve Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Achieve Life competition to find correlations between indicators driving Achieve Life's intrinsic value. More Info.
Achieve Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Achieve Life's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Achieve Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Achieve Life Sciences Systematic Risk
Achieve Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Achieve Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Achieve Life Sciences correlated with the market. If Beta is less than 0 Achieve Life generally moves in the opposite direction as compared to the market. If Achieve Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Achieve Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Achieve Life is generally in the same direction as the market. If Beta > 1 Achieve Life moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Achieve Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Achieve Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Achieve Life growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Achieve Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Achieve Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Achieve Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Achieve Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Achieve Life's daily price indicators and compare them against related drivers.
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.